On April 30, 2026, Cadrenal Therapeutics, Inc. (NASDAQ: CVKD) announced an ‘End-of-Phase 2’ meeting with the U.S. Food and Drug Administration (FDA) in which the agency provided critical guidance on ...
This second project continued the partnership between the Colorado Department of Public Health and Environment (CDPHE) and the Community Engagement, Design and Research (CEDaR) Center to translate ...
Metasurfaces have provided unprecedented freedom for manipulating electromagnetic waves. In metasurface design, massive meta-atoms have to be optimized to produce the desired phase profiles, which is ...
Toxicity monitoring in phase I/II clinical trials with applications at James Graham Brown Cancer Center Clinical Trials. This is an ASCO Meeting Abstract from the 2014 ASCO Annual Meeting I. This ...
The difference between a controller and converter design. Why you want to use a controller versus a converter design. It’s become trendy to multiphase or stack devices as power requirements across ...
Server and computer system architecture has increased in tandem with power delivery (PD) requirements in recent decades. This complicates regulator design since it necessitates a compromise between ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results